文献
J-GLOBAL ID:201802220445087060
整理番号:18A1247574
in silico in vitro in vivoアプローチによる経口結核治療のための潜在的ニトロフラニルメチルピペラジン誘導体IIIM-MCD-211の物理化学的,薬物動態学的,有効性および毒性プロファイリング【JST・京大機械翻訳】
Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach
著者 (17件):
Magotra Asmita
(PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Magotra Asmita
(Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Sharma Anjna
(PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Sharma Anjna
(Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Singh Samsher
(Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Singh Samsher
(Clinical Microbiology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Ojha Probir Kumar
(Drug Theoretics and Chemoinformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India)
,
Kumar Sunil
(Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Kumar Sunil
(Clinical Microbiology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Bokolia Naveen
(Clinical Microbiology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Wazir Priya
(PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Sharma Shweta
(Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Khan Inshad Ali
(Clinical Microbiology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Singh Parvinder Pal
(Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Vishwakarma Ram A.
(Director, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Singh Gurdarshan
(PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
,
Nandi Utpal
(PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India)
資料名:
Pulmonary Pharmacology & Therapeutics
(Pulmonary Pharmacology & Therapeutics)
巻:
48
ページ:
151-160
発行年:
2018年
JST資料番号:
T0708A
ISSN:
1094-5539
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)